 SEATTLE, Oct. 28, 2020 PRNewswire -- A paper published on Zenodo DOI 10.5281zenodo.4119263 by Dr. Steven Quay, M.D., PhD., head of two COVID-19 therapeutic programs at Atossa Therapeutics, Inc. NASDAQ: ATOS, illuminates new scientific observations and conclusions documenting that... 